Handok Overview
- Year Founded
-
1954
- Status
-
Public
- Employees
-
982
- Stock Symbol
-
002390
- Investments
-
17
- Share Price
-
$6.18
- (As of Friday Closing)
Handok General Information
Description
Handok Inc is engaged in the healthcare sector. It is engaged in the business of Prescription drugs, General medicine, in vitro diagnostics, medical devices, Research Products, Medical Devices, Health functional food, General food, Foods for special medical purposes, cosmetics, and Contract manufacturing.
Contact Information
Website
www.handok.co.krCorporate Office
- 132 Teheran-ro
- Gangnam-gu
- Seoul, Gangnam-gu 06235
- South Korea
Corporate Office
- 132 Teheran-ro
- Gangnam-gu
- Seoul, Gangnam-gu 06235
- South Korea
Handok Stock Performance
As of 13-Nov-2026, Handok’s stock price is $6.18. Its current market cap is $80.2M with 13M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $6.18 | $6.18 | $4.18 - $8.30 | $80.2M | 13M | 7.43K | -$0.51 |
Handok Financials Summary
As of 30-Jun-2026, Handok has a trailing 12-month revenue of $386M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 290,221 | 330,711 | 339,321 | 359,009 |
| Revenue | 386,483 | 376,027 | 371,844 | 399,817 |
| EBITDA | 16,727 | 23,766 | (15,934) | 905 |
| Net Income | (6,456) | (1,513) | (38,523) | (22,026) |
| Total Assets | 505,304 | 549,129 | 535,350 | 613,294 |
| Total Debt | 244,107 | 262,898 | 253,497 | 232,805 |
Handok Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Handok Patents
Handok Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026226000-A1 | Compounds with proteolytic activity against kras g12d mutant protein and medical uses thereof | Pending | 23-Apr-2025 | ||
| WO-2026225876-A1 | Crbn protac compounds having egfr mutant protein degradation activity and use thereof | Pending | 23-Apr-2025 | ||
| WO-2026226002-A1 | Crbn protac compounds with egfr mutant proteolytic activity and medical uses thereof | Pending | 23-Apr-2025 | ||
| WO-2026226001-A1 | Vhl protac compounds having egfr mutant protein degradation activity and medical uses thereof | Pending | 23-Apr-2025 | ||
| WO-2026005539-A1 | Composition for external use comprising minoxidil | Pending | 27-Jun-2024 |
Handok Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Handok Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Handok Investments & Acquisitions (17)
Handok’s most recent deal was a Later Stage VC with Dr.Diary for . The deal was made on 08-Jan-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Dr.Diary | 08-Jan-2025 | Later Stage VC | Other Healthcare Technology Systems | ||
| WELT | 25-Jun-2024 | Later Stage VC | Monitoring Equipment | ||
| Sobi-Handok | 17-Apr-2024 | Joint Venture | Pharmaceuticals | ||
| Spark Biopharma | 04-Apr-2022 | Later Stage VC | Other Healthcare Technology Systems | ||
| Spark Biopharma | 25-Nov-2021 | Later Stage VC | Other Healthcare Technology Systems |
Handok ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Handok Exits (4)
Handok’s most recent exit was on 02-Sep-2019 from Adicet Bio. The exit was categorized as with 15 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Adicet Bio | 02-Sep-2019 | Completed |
|
||
| Poongjeon Pharmacy | 01-Jun-2019 | Completed |
|
||
| TRIGR Therapeutics | 25-Mar-2019 | Completed |
|
||
| Tessera Defense and Homeland Security | 20-Feb-2019 | Early Stage VC | Completed |
|
Handok Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Theravalues | Tokyo, Japan | 2007 |
Handok FAQs
-
When was Handok founded?
Handok was founded in 1954.
-
Where is Handok headquartered?
Handok is headquartered in Seoul, South Korea.
-
What is the size of Handok?
Handok has 982 total employees.
-
What industry is Handok in?
Handok’s primary industry is Pharmaceuticals.
-
Is Handok a private or public company?
Handok is a Public company.
-
What is Handok’s stock symbol?
The ticker symbol for Handok is 002390.
-
What is the current stock price of Handok?
As of 13-Nov-2026 the stock price of Handok is $6.18.
-
What is the current market cap of Handok?
The current market capitalization of Handok is $80.2M.
-
What is Handok’s current revenue?
The trailing twelve month revenue for Handok is $386M.
-
What is Handok’s annual earnings per share (EPS)?
Handok’s EPS for 12 months was -$0.51.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
